Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2022-11-22 11:05:08）
  Ikegame Kazuhiro
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
2. Original article　 Effects of Antifungal Stewardship Using Therapeutic Drug Monitoring in Voriconazole Therapy on the Prevention and Control of Hepatotoxicity and Visual Symptoms: A Multicentre Study Conducted in Japan. 2020/08
3. Other　 Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. 2020/07
4. Original article　 Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Myeloid Leukemia Conducted in Japan During the Past Quarter Century. 2020/06
5. Introduction　 Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation. 2020/06
6. Original article　 Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. 2020/03
7. Original article　 Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit. 1991/03
8. Original article　 Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. 1991/03
9. Original article　 Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. 1992/01
10. Original article　 Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells. 1992/01
11. Original article　 Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. 1997/08
12. Original article　 A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus. 1999/12
13. Case report　 Pleural effusion during interferon treatment for chronic hepatitis C. 2000/09
14. Case report　 Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. 2001/07
15. Other　 Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. 2002/07
16. Other　 Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. 2002/07
17. Other　 Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis. 2002/11
18. Case report　 Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling. 2003/03
19. Other　 The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. 2003/03
20. Other　 Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen. 2003/03
21. Case report　 Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin. 2003/06
22. Other　 Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer. 2003/07
23. Other　 Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. 2003/07
24. Original article　 Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. 2003/10
25. Other　 Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). 2003/11
26. Original article　 Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers. 2004/01
27. Other　 Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer. 2004/02
28. Other　 Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors. 2004/03
29. Original article　 Identification of a gene element essential for leukemia-specific expression of transgenes. 2004/03
30. Other　 Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. 2004/03
31. Original article　 Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells. 2004/05
32. Other　 Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation. 2004/06
33. Other　 Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. 2004/07
34. Other　 WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone. 2004/07
35. Other　 Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation. 2004/08
36. Other　 Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. 2004/09
37. Other　 WT1 gene transcript assay for relapse in acute leukemia after transplantation. 2004/09
38. Other　 Successful treatment of tacrolimus (FK506)-related leukoencephalopathy with cerebral hemorrhage in a patient who underwent nonmyeloablative stem cell transplantation. 2004/10
39. Other　 Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection. 2004/12
40. Original article　 Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies. 2005/02
41. Original article　 HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism. 2005/04
42. Other　 A case of immune recovery vitritis induced by donor leukocyte infusion for the treatment of cytomegalovirus retinitis. 2005/10
43. Case report　 Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient. 2006/08
44. Other　 Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. 2006/10
45. Other　 Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. 2008/01
46. Other　 Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. 2008/08
47. Other　 Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. 2008/09
48. Other　 Hepatosplenic alphabeta T cell lymphoma. 2010/04
49. Other　 Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. 2010/04
50. Other　 Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. 2010/09
51. Other　 Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. 2010/10
52. Other　 Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. 2011/01
53. Other　 Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. 2011/02
54. Other　 Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation. 2011/04
55. Other　 Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan. 2011/04
56. Other　 Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. 2011/08
57. Other　 Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria. 2011/10
58. Other　 Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation. 2011/12
59. Original article　 Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning 2012/03
60. Other　 Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. 2012/04
61. Other　 Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study. 2012/04
62. Original article　 Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT 2012/04
63. Original article　 Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome 2012/05
64. Other　 Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients. 2012/07
65. Other　 Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. 2012/08
66. Original article　 Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors 2012/10
67. Other　 Haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region)--who should be a donor? 2012/12
68. Other　 Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy. 2012/12
69. Other　 Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. 2012/12
70. Original article　 Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR 2013/01
71. Original article　 Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. 2013/05
72. Original article　 Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. 2013/05
73. Original article　 Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD. 2013/06
74. Original article　 Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation. 2013/06
75. Original article　 Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2013/07
76. Original article　 Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. 2013/08
77. Original article　 Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine. 2013/10
78. Original article　 Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2013/11
79. Original article　 Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease 2014/02
80. Original article　 Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. 2014/04
81. Original article　 Risk analysis of falls in patients undergoing allogeneic hematopoietic stem cell transplantation. 2014/08
82. Original article　 Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT 2014/09
83. Original article　 Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopietic Stem Cell transplantation Using Generalized Additive Model. 2015/04
84. Original article　 Pharmacokinetics of 8 mg/kg anti-human T-lymphocyte rabbit immunoglobulin conditioning for hematopoietic stem cell transplantation in Japanese patients. 2015/05
85. Other　 A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch. 2015/07
86. Original article　 Unmanipulated HaploidenticalReduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. 2015/08
87. Original article　 Balance function in patients who had undergone allogeneic hematopoietic stem cell transplantation. 2015/09
88. Original article　 Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
89. Other　 Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients. 2015/10
90. Original article　 Host Foxp3+CD4+ Regulatory T Cells Act as a Negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology. 2016/01
91. Case report　 Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity. 2016/02
92. Original article　 Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. 2016/11
93. Original article　 Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHC 2017/02
94. Case report　 Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation 2017/05
95. Original article　 Spousal hematopoietic stem cell transplantation 2017/05
96. Original article　 Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation 2017/07
97. Original article　 Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation 2017/10
98. Original article　 Fatigue, Muscle Oxygen Consumption and Blood Flow to the Skeletal Muscle After Allogeneic Hematopoietic Stem Cell Transplantation. 2018
99. Other　 Hemoglobin Dynamics in the Skeletal Muscle of Patients with Malignant Hematopoietic Disease. 2018/01
100. Original article　 A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. 2018/04
101. Original article　 Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR. 2018/04
102. Original article　 Impaired skeletal muscle oxygenation following allogeneic hematopoietic stem cell transplantation is associate with exercise capacity 2018/07
103. Original article　 Changes in Borg scale for resistance training and test of exercise tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation. 2018/09
104. Original article　 Hemoglobin Dynamics in the Skeletal Muscle of Patients with Malignant Hematopoietic Disease. 2018/09
105. Case report　 Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor. 2019/03
106. Original article　 HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. 2019/05
107. Other　 HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. 2019/05
108. Original article　 Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
109. Original article　 Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. 2019/07
110. Other　 Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. 2019/07
111. Original article　 Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
112. Original article　 Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups. 2019/08
113. Original article　 Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups. 2019/08
114. Original article　 Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry. 2019/09
115. Original article　 Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia. 2019/09
116. Original article　 Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2019/09
117. Case report　 Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor. 2019/10
118. Original article　 Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. 2019/11
119. Original article　 Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation. 2019/12
120. Original article　 Relationship Between Exercise Capacity and Muscle O2 2020
121. Other　 Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease. 2020/01
122. Original article　 Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Grou 2020/01
123. Original article　 Relationship Between Exercise Capacity and Muscle O2Hb Saturation in Patients Before Hematopoietic Stem-Cell Transplantation. 2020/01
124. Original article　 Relationship Between Muscle Oxygen Saturation and Exercise Load in Patients with Malignant Hematopoietic Disease 2020/01
125. Original article　 Could the minimum number of haematopoietic stem cells to obtain engraftment exist in unrelated, single cord blood transplantation? 2020/02
126. Original article　 A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan. 2020/03
127. Original article　 Heterogeneous Impact of Cytomegalovirus Reactivation on Nonrelapse Mortality in Hematopoietic Stem Cell Transplantation. 2020/03
128. Original article　 Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study. 2020/03
129. Original article　 Relationship Between Exercise Capacity and Muscle O(2)Hb Saturation in Patients Before Hematopoietic Stem-Cell Transplantation 2020/06
130. Original article　 Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission 2020/07
131. Case report　 Toxoplasmic Encephalitis Followed by Primary EBV-Associated Post-Transplant Lymphoproliferative Disorder of the Central Nervous System in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Report 2020/08
132. Other　 Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation. 2020/09
133. Original article　 Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria 2020/09
134. Original article　 Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection. 2020/12
135. Original article　 Muscle oxygen extraction and lung function are related to exercise tolerance after allogeneic hematopoietic stem cell transplantation 2021/03
136. Original article　 Muscle oxygen extraction and lung function are related to exercise tolerance after allogeneic hematopoietic stem cell transplantation 2021/08
137. Original article　 Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. 2021/09
138. Original article　 Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. 2021/09
139. Original article　 Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group. 2021/12
140. Original article　 Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation. 2021/12
141. Original article　 Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. 2022/01
142. Original article　 Deletion of Y-chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors. 2022/02
143. Original article　 Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia. 2022/03
144. Original article　 HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation. 2022/03
145. Original article　 Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group. 2022/04
146. Original article　 Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. 2022/04
Display 5 items
Display all(146)
■ Presentation
1. Higher corticosteroid dose declines physical function, but does not affect psychosocial function among allogeneic hematopoietic stem-cell transplantation patients  2013/06
2. Effect of physical therapy on physical function and QOL in patients undergoing allogeneic hematopoietic transplantation  2013/09
3. HLA haploidentical transplantation and further.  2013/11/03
4. haploidentical transplantation and further  2014/04
5. Early-phase differences in health-related QOL, psychological status, and physical function between HLA-haploidentical and other allo-HSCT recipients  2014/06
6. Graft-versus-GVHD, a second transplantation from another donor for the resucue from refractory acute GVHD.  2014/09
7. Morning Discussion (Meet the Expert)  2014/10
8. Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopietic Stem Cell transplantation Using Generalized Additive Model  2015/02
9. Spousal Hematopoietic Stem Cell Transplantation for Post-transplantation Relapse/Rejection.  2015/02
10. The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotype: A Retrospective Analysis of The JSHCT HLA Working Group Study  2015/02
11. “Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disease Prophylaxis.  2015/02
12. Hematopoietic stem cell transplantation using a related donor not sharing HLA-haplotype  2015/03/06
13. Maturation of dendritic cells restrained by host Foxp3+CD4+regulatory T cells: the critical role in the induction of graft-veusus-host reaction after experimental BMT.  2015/03/06
14. The balance function in patients undergoing allogeneic hematopoietic transplantation.  2015/03/06
15. The haplo-mini-SCT for the secondary central nervous system (CNS) lymphoma  2015/03/06
16. The impact of HLA-mismatch only in the HVG direction on the outcome of related hematopoietic stem cell transplantation for patients with HLA-homozygous haplotypes: a retrospective analysis of JSHCT HLA working group.  2015/03/06
17. Based on haplo, beyond haplo.  2015/03/07
18. Risk analysis of falls and skin lesions in patients undergoing allogeneic hematopoietic stem cell transplantation.  2016/02
19. Unmanipulated HLA haploidentical allogeneic stem cell transplantation from family members using Steroid-containing GVHD prophylaxis for refractory hematological malignancies.  2016/02
20. A case report with MDS who underwent haploindentical transplantation after umbilical cord blood transplantation with Mixed cheimerism state over a long period of time.  2016/03/04
21. Allogeneic Stem Cell Transplantation for X-linked agammaglobulinemia as a model of the reconstitution of humoral immunity  2016/03/04
22. clinical outcomes of HLA haploidentical hematopoietic stem cell transplantation in patients with Philadelphia Chromosome positive Acute Lymphoblastic Leukemia in our institute  2016/03/04
23. Graft-versus-host disease-free,relapse-free,survival(GRFS)of patients with hematological malignancy according to donor type: JSHCT Working Group study.  2016/03/04
24. Hyogo haplo should be best for AML PIF in young patients with spared organ function and ADL  2016/03/05
25. Unmanipulated haploidentical RIST using Fludarabine, Busulfan, low-dose ATG and steroid for patients in non-CR or at high risk of relapse: a prospective multicenter phase III study in Japan.”  2016/05
26. A case of cerebral toxoplasmosis and EBV-associated post-transplant lymphoproliferative disorder of the central nervous system following allogeneic hematopoietic stem cell transplantation  2017/03/02
27. Effective Desensitization of Donor-specific HLA Antibodies Using Platelet Transfusion Bearing Targeted HLA in a Case of HLA-mismatched Allogeneic Stem Cell Transplantation  2017/03/02
28. One example of acute myeloid leukemia for severe hepatic dysfunction due to acute GVHD who underwent living donor liver transplantation from hematopoietic stem cell donor  2017/03/02
29. The investigation of resistance exercise load and perceived exertion in patients undergoing allogeneic hematopoietic transplantation  2017/03/02
30. Physilogical characteristics of the 6-minute walk test in patients undergoing allogeneic hematopoietic transplantation  2017/03/03
31. Team approach to allo-hematopoietic stem cell transplantation:From the physical therapist's view  2017/03/03
32. Association beteween plasma concentration of antithymocyte globulin(ATG) and acute graft versus host disease(GVHD) granding on haploidentical hematopoietic stem cell transplantation  2017/03/04
33. Relationship between muscle endurance and muscle oxidative consumption in patients who received allogeneic hematopoietic stem cell transplantation  2017/06/27
34. Effectiveness of balance exercise assist robot (BEAR) for allogeneic hematopoietic stem cell transplantation patients: a preliminary study  2017/06/28
35. Muscle oxygen consumption and blood flow to the skeletal muscle in patients with malignant hematopoietic disease  2017/08/19
36. Muscle oxidative extraction in patients with hematological malignancy  2018/02/01
37. Prognostic value of WT1 on HLA-haploidentical RIST for non-remission leukemia  2018/02/02
38. Relationship of 6-minute walk test,muscle strength,and physiological response in HSCT patients  2018/02/02
39. Relationship of resistance exercise and perceived exertion in HSCT patients  2018/02/02
40. Prediction of hemorrhagic cystitis using antibody to ADV type11 and prophylastic value of cidofovir  2018/02/03
41. Muscle oxygen saturation during muscle endurance test in patients with malignant hematopoietic disease  2018/07/03
42. Relationship between exercise capacity and muscle O2Hb saturation in patients before hematopoietic stem-cell transplantation  2018/07/04
43. The effect of balance exercise assist robot (BEAR) to patient after allogenetic hematopoietic stem cell transplantation (allo-HSCT); preliminally study.  2018/07/08
44. Changes in heart rate and Borg scale after the exercise-tolerance test in allogeneic hematopoietic stem cell transplantation patients  2018/07/11
45. Detailed bone marrow plasma cell phenotyping in the patients with suspected plasma cell disorders.  2018/10/14
46. Dose CMV reactivation reduce AML relapse risk in HCM-style HLA-haploidentical RIST?  2019/03/08
47. Granulocyte collections using Spectra Optia with or without the use of hydroxyethy1 starch  2019/03/08
48. HLA haploidentical transpantation in AYAs  2019/03/08
49. HLA-mismatched stem cell transplantation from family members for super-high risk disease  2019/03/08
50. Isohemagglotinin production after minor ABO-incompatible peripheral blood stem cell transplantation  2019/03/08
51. Steroid-resistant,homeostatically-proliferationg donor T cells in BM suppresses GVHD preserving GVL  2019/03/08
52. Usefulness of measuring hematology analyzer-based HPC in peripheral blood stem cell harvest  2019/03/08
53. Retrospective analysis of allogeneic stem cell transplantation for PNH  2019/03/09
54. Secondary malignancies after hematopoietic stem cell transplantation in Hyogo college of medicine  2019/03/09
55. Verification of the availability of allogeneic stem cell source based on the transplant achievement  2019/03/09
56. Impaired muscle oxygen consumption during exercise after allo-HSCT is related to lower muscle mass at the time of engraftment in a sterile isolation room  2019/06/11
57. The effect of Balance Exercise Assist Robot (BEAR) is related to balance function before intervention in patients after allogeneic hematopoetic stem cell transplantation.  2019/06/11
58. The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia in First Remission in the Era of High-intensity Chemotherapy.  2019/12
59. Phase II trial of fecal microbiota transplantation for steroid-resistant gastrointestinal acute GVHD  2020/03
60. anti-NMDAR encephalitis after HLA haploidentical stem cell transplantation  2020/03/06
61. Haploidentical and cord blood salvage transplantation for graft failure after allogeneic hematopoietic stem cell transplantation  2020/03/06
62. Phamacokinetics of cidofovir in Japanese patients receiving hematopoietic stem cell transplantation  2020/03/06
63. Acute GVHD after autologous in PBSCT in a patient with DLBCL  2020/03/07
64. Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison  2020/03/07
65. Effect of allogeneic SCT in AML patients with or without extramedullary disease  2020/03/07
66. Effect of letermovir on blood concentration of voriconazole  2020/03/07
67. Haploidentical SCT with steroid-containing GVHD prophylaxis for AML in non-CR:comarison with matched sibling SCT from the TRUMP data  2020/03/07
68. Unmanipulated haploientical stem cell transplantation using low-dose ATG and steroid for high-risk disease  2020/03/07
69. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukaemia with high hyperdiploidy: A retrospective nationwide study of the Japan Society for Hematopoietic Cell Transplantation  2020/06
70. Decision making in AYA patients with hematological malignancy underwent HLA mismatch transplants.  2021/03
71. Survival-time analysis using recurrent neural networks in hematopoietic stem cell transplantation  2021/03
72. Tisagenlecleucel for Diffuse Large B-cell Lymphoma:A Single Center Experience  2021/03
73. Two cases of incidental plasma cell neoplasm: diagnostic roles of EMA and CD79a immunohistochemistry  2021/09/23
Display 5 items
Display all(73)
mail